CCM
RNAM

Cinctive Capital Management’s Avidity Biosciences RNAM Stock Holding History

Cinctive Capital Management’s Portfolio RNAM Stock Details RNAM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-50,000
Closed -$1.45M – 438
2024
Q4 		$1.45M Buy
+50,000
New +$2.09M 0.07% 255

Other funds holding RNAM

CC
Corsicana & Co Corsicana, Texas $158M AUM

Cinctive Capital Management's RNAM Position: Q1 2026 in Review

Cinctive Capital Management sold out of Avidity Biosciences (RNAM) in Q1 2026, closing a stake of 50,000 shares — an estimated $3.61M sold.

Cinctive Capital Management first reported a position in RNAM in Q2 2024 and held it in 5 quarters. The position peaked at $3.61M in Q4 2025. 1 fund tracked by Wall St. Rank holds RNAM as of Q1 2026.

  • Cinctive Capital Management reported no remaining Avidity Biosciences position as of Q1 2026 after selling out during the quarter.
  • Cinctive Capital Management sold 50,000 Avidity Biosciences shares in Q1 2026, an estimated $3.61M.
  • Cinctive Capital Management first reported a position in Avidity Biosciences in Q2 2024 and held it in 5 quarters.
  • Cinctive Capital Management's Avidity Biosciences position peaked at $3.61M in Q4 2025.
  • 1 fund tracked by Wall St. Rank held Avidity Biosciences as of Q1 2026.

Based on Cinctive Capital Management's 13F filing for Q1 2026, filed 15 May 2026.